Form 4 for ADPT Adaptive Biotechnologies Corp
Accepted 2023-03-08 00:00:00 ET · period of report 2023-03-06 · accession 0001062993-23-006336 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-08 | 2023-03-06 | ADPT | OWEN KATEY EINTERZ | Dir | A - Grant | $0.00 | +14.8K | 25.9K | +133% | $0 |
| D | 2023-03-08 | 2023-03-06 | ADPT | OWEN KATEY EINTERZ | Dir | A - Grant | $0.00 | +23.3K | 23.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-06 | A | A | 14,775 | $0.00 | 25,907 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2023-03-06 | A | A | 23,329 | $0.00 | 23,329 | D | $8.46 · — to 2033-03-06 | 23,329 Common Stock | (F1) The option will vest in equal monthly installments over one year from March 4, 2023, subject to continued service as a director through such vesting dates. |